{"id":"https://openalex.org/W4286295703","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps3165","title":"A phase 2 study of the MDM2 inhibitor milademetan in patients with TP53-wild type and MDM2-amplified advanced or metastatic solid tumors (MANTRA-2).","display_name":"A phase 2 study of the MDM2 inhibitor milademetan in patients with TP53-wild type and MDM2-amplified advanced or metastatic solid tumors (MANTRA-2).","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4286295703","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps3165"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.tps3165","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps3165","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps3165","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113033878","display_name":"Ecaterina E Ileana Dumbrava","orcid":"https://orcid.org/0000-0002-1959-0536","observed_orcids":["https://orcid.org/0000-0002-1959-0536"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ecaterina Elena Dumbrava","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036875036","display_name":"Glenn J. Hanna","orcid":"https://orcid.org/0000-0002-9969-2523","observed_orcids":["https://orcid.org/0000-0002-9969-2523"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glenn J. Hanna","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105923745","display_name":"Gregory Michael Cote","orcid":"https://orcid.org/0000-0003-0181-886X","observed_orcids":["https://orcid.org/0000-0003-0181-886X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Michael Cote","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014554706","display_name":"Thomas E. Stinchcombe","orcid":"https://orcid.org/0000-0002-3595-8011","observed_orcids":["https://orcid.org/0000-0002-3595-8011"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom Stinchcombe","raw_affiliation_strings":["Duke Cancer Institute, Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute, Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049294543","display_name":"Melissa Lynne Johnson","orcid":"https://orcid.org/0000-0001-9874-1314","observed_orcids":["https://orcid.org/0000-0001-9874-1314"]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Lynne Johnson","raw_affiliation_strings":["Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN;","institution_ids":["https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102709933","display_name":"Christopher T. Chen","orcid":"https://orcid.org/0000-0001-8962-3527","observed_orcids":["https://orcid.org/0000-0001-8962-3527","https://orcid.org/0000-0001-8911-0203","https://orcid.org/0000-0002-6527-7022"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Chen","raw_affiliation_strings":["Stanford University School of Medicine, Palo Alto, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University School of Medicine, Palo Alto, CA;","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088846258","display_name":"Siddhartha H. K. Devarakonda","orcid":"https://orcid.org/0000-0003-2693-3848","observed_orcids":["https://orcid.org/0000-0003-2693-3848"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siddhartha Devarakonda","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082563712","display_name":"Naisargee Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naisargee Shah","raw_affiliation_strings":["Rain Therapeutics, Inc., Newark, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rain Therapeutics, Inc., Newark, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020050141","display_name":"Feng Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feng Xu","raw_affiliation_strings":["Rain Therapeutics, Inc., Newark, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rain Therapeutics, Inc., Newark, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034705456","display_name":"Robert Charles Doebele","orcid":"https://orcid.org/0000-0001-6728-6857","observed_orcids":["https://orcid.org/0000-0001-6728-6857"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Charles Doebele","raw_affiliation_strings":["Rain Therapeutics, Inc., Newark, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rain Therapeutics, Inc., Newark, CA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034595315","display_name":"Mrinal M. Gounder","orcid":"https://orcid.org/0000-0001-8468-0119","observed_orcids":["https://orcid.org/0000-0001-8468-0119"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mrinal M. Gounder","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"TPS3165","last_page":"TPS3165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/milademetan","display_name":"milademetan","score":0.9570000171661377},{"id":"https://openalex.org/keywords/mdm2-inhibitors","display_name":"MDM2 inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/wild-type-p53","display_name":"wild-type p53","score":0.781000018119812},{"id":"https://openalex.org/keywords/mdm2-amplification","display_name":"MDM2 amplification","score":0.9800000190734863},{"id":"https://openalex.org/keywords/p53-restoration","display_name":"p53 restoration","score":0.718999981880188},{"id":"https://openalex.org/keywords/liposarcoma","display_name":"liposarcoma","score":0.640999972820282},{"id":"https://openalex.org/keywords/intimal-sarcoma","display_name":"intimal sarcoma","score":0.7670000195503235},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.34700000286102295},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5730000138282776},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.4449999928474426},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6539999842643738},{"id":"https://openalex.org/keywords/oral-targeted-therapy","display_name":"oral targeted therapy","score":0.3240000009536743},{"id":"https://openalex.org/keywords/basket-trials","display_name":"basket trials","score":0.37599998712539673}],"concepts":[{"id":"https://openalex.org/C2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","level":3,"score":0.7592716217041016},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6492865681648254},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6095520853996277},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.49086958169937134},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4446752071380615},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.37730738520622253},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.37301671504974365},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2707085609436035},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2653741240501404},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2416704297065735},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21931007504463196},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09065544605255127}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.tps3165","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps3165","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps3165","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.75,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282914532","https://openalex.org/W4413100569","https://openalex.org/W4389227602","https://openalex.org/W4200383547","https://openalex.org/W4282965409","https://openalex.org/W4282963912","https://openalex.org/W4281705492","https://openalex.org/W2947306414","https://openalex.org/W4200593165","https://openalex.org/W4307910995"],"abstract_inverted_index":{"TPS3165":[0],"Background:":[1],"Murine":[2],"double":[3],"minute":[4],"2":[5],"(MDM2)":[6],"is":[7,112,160,224,257,279,338,363],"a":[8,51,152,161,228,274],"potent":[9],"negative":[10],"regulator":[11],"of":[12,20,35,55,71,85,95,123,156,177,198,273,305,320,335],"the":[13,69,90,172],"tumor":[14,40,134,137,330],"suppressor":[15,41],"p53.":[16],"MDM2":[17,36,78,82,119,146,184,222,229,255,351],"induces":[18],"degradation":[19],"p53":[21,39],"and":[22,28,66,106,128,221,271,289,291,350,362],"promotes":[23],"tumorigenesis":[24],"in":[25,43,141,151,179,327,359],"solid":[26,58,96,181,210],"tumors,":[27],"preclinical":[29],"models":[30,131],"have":[31,345],"shown":[32],"that":[33,68,342],"inhibition":[34],"can":[37],"restore":[38],"activity":[42],"TP53-wild":[44],"type":[45],"(WT),":[46],"MDM2-amplified":[47,125],"tumors.":[48],"We":[49],"performed":[50],"mutual":[52],"exclusivity":[53],"analysis":[54],"patients":[56,144,192,337,344],"with":[57,76,145,183,200,238,253],"tumors":[59,97,182,211,248],"(n":[60],"=":[61],"42,125;":[62],"AACR":[63],"Project":[64],"GENIE)":[65],"found":[67],"frequency":[70],"co-occurring":[72],"TP53":[73,219,348],"mutations":[74],"decreased":[75],"increasing":[77],"copy":[79,83,147,230,352],"number.":[80],"An":[81,92],"number":[84,148,187,231,353],"12":[86,150,233,294],"was":[87,139],"chosen":[88],"as":[89,227],"threshold.":[91],"estimated":[93],"1.1%":[94],"meet":[98],"this":[99,110],"molecular":[100],"criteria,":[101],"excluding":[102],"glioblastomas,":[103],"dedifferentiated":[104],"liposarcomas,":[105,240],"intimal":[107,241],"sarcomas":[108],"where":[109],"signature":[111],"enriched.":[113],"Milademetan":[114],"(RAIN-32),":[115],"an":[116,254],"oral,":[117],"selective":[118],"inhibitor,":[120],"inhibits":[121],"growth":[122,309],"TP53-WT/":[124],"cell":[126],"lines":[127],"patient-derived":[129],"xenograft":[130],"from":[132],"varying":[133],"types.":[135],"Furthermore,":[136],"regression":[138],"observed":[140],"3/3":[142],"non-liposarcoma":[143],">":[149],"phase":[153,162],"1":[154],"trial":[155,168,357,368],"milademetan.":[157],"MANTRA-2":[158],"(RAIN-3202)":[159],"2,":[163],"multicenter,":[164],"single-arm,":[165],"open-label,":[166],"basket":[167],"designed":[169],"to":[170,213,340],"evaluate":[171],"efficacy":[173],"or":[174,208,234,243],"clinical":[175],"benefit":[176],"milademetan":[178,262],"TP53-WT":[180],"amplification":[185,223],"(copy":[186],"\u2265":[188,195,232,354],"12).":[189],"Methods:":[190],"Eligible":[191],"must":[193],"be":[194],"18":[196],"years":[197],"age":[199],"histologically":[201],"and/or":[202,329],"cytologically":[203],"confirmed":[204,347],"locally":[205],"advanced,":[206],"incurable":[207],"metastatic":[209],"refractory":[212],"standard":[214],"therapy.":[215],"Local":[216],"testing":[217],"demonstrating":[218],"WT":[220,349],"required,":[225],"defined":[226],"6-fold":[235],"increase.":[236],"Patients":[237,260],"well-differentiated/de-differentiated":[239],"sarcomas,":[242],"primary":[244],"central":[245],"nervous":[246],"system":[247],"are":[249],"excluded.":[250],"Prior":[251],"treatment":[252],"inhibitor":[256],"not":[258],"permitted.":[259],"receive":[261],"260":[263],"mg":[264],"orally":[265],"once":[266],"daily":[267],"on":[268],"Days":[269],"1\u20133":[270],"15\u201317":[272],"28-day":[275],"cycle.":[276],"Tumor":[277],"response":[278,299],"evaluated":[280],"by":[281],"RECIST":[282],"v1.1":[283],"at":[284],"Weeks":[285],"8,":[286],"16,":[287],"24,":[288],"32,":[290],"then":[292],"every":[293],"weeks.":[295],"Primary":[296],"endpoint:":[297],"objective":[298],"rate.":[300],"Secondary":[301],"endpoints":[302,324],"include:":[303,325],"duration":[304],"response;":[306],"progression-free":[307],"survival;":[308,316],"modulation":[310],"index;":[311],"disease":[312],"control":[313],"rate;":[314],"overall":[315],"safety;":[317],"health-related":[318],"quality":[319],"life":[321],"scores.":[322],"Exploratory":[323],"biomarkers":[326],"blood":[328],"tissue;":[331],"pharmacodynamics;":[332],"pharmacokinetics.":[333],"Enrollment":[334],"65":[336],"planned":[339],"ensure":[341],"57":[343],"centrally":[346],"12.":[355],"The":[356],"opened":[358],"November":[360],"2021":[361],"actively":[364],"enrolling":[365],"patients.":[366],"Clinical":[367],"information:":[369],"NCT05012397.":[370]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-07-21T00:00:00"}